Briacell Therapeutics Corp Stock Net Asset
| BCTXW Stock | USD 0.35 0.06 20.69% |
BriaCell Therapeutics Corp fundamentals help investors to digest information that contributes to BriaCell Therapeutics' financial success or failures. It also enables traders to predict the movement of BriaCell Stock. The fundamental analysis module provides a way to measure BriaCell Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BriaCell Therapeutics stock.
BriaCell |
BriaCell Therapeutics Corp Company Net Asset Analysis
BriaCell Therapeutics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current BriaCell Therapeutics Net Asset | 5.87 M |
Most of BriaCell Therapeutics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BriaCell Therapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, BriaCell Therapeutics Corp has a Net Asset of 5.87 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
BriaCell Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BriaCell Therapeutics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BriaCell Therapeutics could also be used in its relative valuation, which is a method of valuing BriaCell Therapeutics by comparing valuation metrics of similar companies.BriaCell Therapeutics is currently under evaluation in net asset category among its peers.
BriaCell Fundamentals
| Return On Equity | -2.06 | ||||
| Return On Asset | -1.26 | ||||
| Number Of Shares Shorted | 2.81 K | ||||
| EBITDA | (4.79 M) | ||||
| Net Income | (4.93 M) | ||||
| Total Debt | 8.56 M | ||||
| Book Value Per Share | (0.13) X | ||||
| Cash Flow From Operations | (24.13 M) | ||||
| Beta | 1.82 | ||||
| Market Capitalization | 48.08 M | ||||
| Total Asset | 5.87 M | ||||
| Retained Earnings | (85.44 M) | ||||
| Working Capital | (3.81 M) | ||||
| Net Asset | 5.87 M |
About BriaCell Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BriaCell Therapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BriaCell Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BriaCell Therapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.